Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison L Naleway

Showing results (11-20 of 234) with videos related to

Pageof 24
Sort By:
Journal of Women'S Health (2002)|January 11, 2012
Reported adverse events in young women following quadrivalent human papillomavirus vaccinationAllison L Naleway, Rachel Gold, Lois Drew, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 31, 2006
Gender differences in asthma management and quality of lifeAllison L Naleway, William M Vollmer, E Ann Frazier, et al.
Sexually Transmitted Diseases|December 28, 2019
Temporal Trends in the Incidence of Anogenital Warts: Impact of Human Papillomavirus VaccinationAllison L Naleway, Bradley Crane, Ning Smith, et al.
Vaccine|September 22, 2009
Risk of immune hemolytic anemia in children following immunizationAllison L Naleway, Edward A Belongia, James G Donahue, et al.
Plos One|February 12, 2015
Pregnancy after treatment for cervical cancer precursor lesions in a retrospective matched cohortAllison L Naleway, Sheila Weinmann, Girishanthy Krishnarajah, et al.
American Journal of Epidemiology|June 6, 2002
Lyme disease incidence in Wisconsin: a comparison of state-reported rates and rates from a population-based cohortAllison L Naleway, Edward A Belongia, James J Kazmierczak, et al.
Sexually Transmitted Diseases|July 12, 2014
Evaluation of a surveillance case definition for anogenital warts, Kaiser Permanente northwestAllison L Naleway, Sheila Weinmann, Brad Crane, et al.
Vaccine|May 29, 2018
Feasibility of a pilot intervention to reduce pain and syncope during adolescent vaccinationMichelle L Henninger, Jennifer L Kuntz, Alison J Firemark, et al.
JAMA|April 22, 2022
Receipt of COVID-19 Booster Dose Among Fully Vaccinated Pregnant Individuals Aged 18 to 49 Years by Key DemographicsHilda Razzaghi, Mehreen Meghani, Bradley Crane, et al.
Vaccine|July 22, 2014
Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse eventsJames D Nordin, Elyse Olshen Kharbanda, Gabriela Vazquez-Benitez, et al.
Pageof 24

Showing results (11-20 of 234) with videos related to

Sort By:
Pageof 24
Journal of Women'S Health (2002)|January 11, 2012
Reported adverse events in young women following quadrivalent human papillomavirus vaccinationAllison L Naleway, Rachel Gold, Lois Drew, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 31, 2006
Gender differences in asthma management and quality of lifeAllison L Naleway, William M Vollmer, E Ann Frazier, et al.
Sexually Transmitted Diseases|December 28, 2019
Temporal Trends in the Incidence of Anogenital Warts: Impact of Human Papillomavirus VaccinationAllison L Naleway, Bradley Crane, Ning Smith, et al.
Vaccine|September 22, 2009
Risk of immune hemolytic anemia in children following immunizationAllison L Naleway, Edward A Belongia, James G Donahue, et al.
Plos One|February 12, 2015
Pregnancy after treatment for cervical cancer precursor lesions in a retrospective matched cohortAllison L Naleway, Sheila Weinmann, Girishanthy Krishnarajah, et al.
American Journal of Epidemiology|June 6, 2002
Lyme disease incidence in Wisconsin: a comparison of state-reported rates and rates from a population-based cohortAllison L Naleway, Edward A Belongia, James J Kazmierczak, et al.
Sexually Transmitted Diseases|July 12, 2014
Evaluation of a surveillance case definition for anogenital warts, Kaiser Permanente northwestAllison L Naleway, Sheila Weinmann, Brad Crane, et al.
Vaccine|May 29, 2018
Feasibility of a pilot intervention to reduce pain and syncope during adolescent vaccinationMichelle L Henninger, Jennifer L Kuntz, Alison J Firemark, et al.
JAMA|April 22, 2022
Receipt of COVID-19 Booster Dose Among Fully Vaccinated Pregnant Individuals Aged 18 to 49 Years by Key DemographicsHilda Razzaghi, Mehreen Meghani, Bradley Crane, et al.
Vaccine|July 22, 2014
Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse eventsJames D Nordin, Elyse Olshen Kharbanda, Gabriela Vazquez-Benitez, et al.
Pageof 24